Navigation Links
Mast Therapeutics Hosting 2nd Annual Sickle Cell Disease Therapeutics Conference On September 19, 2013
Date:9/6/2013

SAN DIEGO, Sept. 6, 2013 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced the 2nd Annual Sickle Cell Disease Therapeutics Conference will take place on September 19th, 2013 at the Four Seasons Hotel in New York City (Cosmopolitan Suite). The conference is intended to serve as a forum to raise awareness for sickle cell disease and will include presentations from leading companies in sickle cell disease and discussions with experts regarding the latest advancements and trends in treatment.  Conference sponsors include The Pierre Fabre Foundation, Canaccord Genuity, Piper Jaffray, Sheppard Mullin Richter & Hampton, LLP, Pharm-Olam International and Theradex Systems, Inc.

Six public and private companies developing new treatment options for patients with sickle cell disease, including bluebird bio (NASDAQ GS: BLUE) and Mast Therapeutics, Inc. (NYSE MKT: MSTX) will be presenting. 

Conference attendees will hear from leaders in the sickle cell disease medical and advocacy communities, including:

  • Althea Grant, PhD, Chief of the Epidemiology and Surveillance Branch in the Division of Blood Disorders of the National Center on Birth Defects and Developmental Disabilities at the Centers for Disease Control
  • Wally R. Smith, MD, Professor of Medicine at Virginia Commonwealth University
  • Susan P. Perrine, MD, Professor, Pediatrics, Medicine, Pharmacology and Experimental Therapeutics Cancer Center; Director, Hemolgobinopathy Thalassemia Research Unit at the Boston University School of Medicine
  • Gary A. Gibson, P
    '/>"/>

SOURCE Mast Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014  Beamz Interactive, ... interactive music products, today announced that it has ... leading manufacturer and supplier of innovative prosthetic, orthotic ... As part of the agreement, RSL Steeper will ... solution specifically configured for use within UK residential ...
(Date:12/17/2014)...  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) ... (USPTO) has issued a key patent covering ImmunoCellular,s ... targeting six tumor antigens that are commonly expressed ... 8,871,211, which issued October 28, 2014, include methods ... cell composition comprising peptide epitopes of the six ...
(Date:12/17/2014)... MARLBOROUGH, Mass. , Dec. 17, 2014 /PRNewswire/ ... a biotechnology company focused on discovering, developing and ... using RNA-targeted technologies, today announced completion of enrollment in ... results from the 3-month observations confirmed the 1-month ... year:  Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
Breaking Medicine Technology:Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
... 2011 FDA Commissioner Margaret A. Hamburg, M.D., ... can be taken to drive biomedical innovation, while ... http://photos.prnewswire.com/prnh/20090824/FDALOGO) Titled "Driving Biomedical Innovation: Initiatives ... concerns about the sustainability of the medical product ...
... ConvaTec, a world-leading developer and marketer of innovative medical ... Ltd, a wholly-owned subsidiary of ConvaTec Holdings UK Ltd, has ... the home delivery of stoma and continence care products. ... of England, and as a well-respected company in the home ...
Cached Medicine Technology:FDA Commissioner Outlines Steps to Spur Biomedical Innovation, Improve Health of Americans 2ConvaTec Announces Acquisition of Farnhurst Medical 2
(Date:12/19/2014)... December 19, 2014 B. E. Smith, ... healthcare providers, has been retained to lead a national ... Medical Center in Estes Park, Colo. The top executive ... has recently placed more than 900 healthcare executives into ... a 25-bed, not-for-profit critical access hospital and level IV ...
(Date:12/19/2014)... Hands On Mobile Spa, has announced they ... On Wheels has been transformed into a utopia for the ... seems to disappear. The Virtual Tour showcases the beauty of ... corporate events and more. , The Virtual Tour shows viewers ... is actually an overhauled Winnebago. Marla Kaplan-Pelle, Director states " ...
(Date:12/19/2014)... Slone Partners , a national recruitment ... technology, and laboratory testing industries, has promoted Leslie ... The announcement comes after a year of expansion ... in Boston and several new additions to the ... client experience," said Adam Slone, Chief Executive Officer. ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 The ... ski club in Southern Vermont’s Deerfield Valley, announced today ... inspired by classic rock songs. , Three time ... with a private concert followed by a trail naming ... new trail names include: “I’m Alright” the theme song ...
(Date:12/19/2014)... By Amy Norton ... -- Children born to moms who were exposed to high ... increased risk of developing autism, a U.S. study suggests. ... birth between 1990 and 2002, those exposed to the most ... a baby who later developed autism. And exposure during the ...
Breaking Medicine News(10 mins):Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 3Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 2Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 3Health News:Slone Partners Promotes Leslie Loveless to Chief Operating Officer 2Health News:The Hermitage Club Officially Names Four Ski Trails after Iconic Rock Songs by Grammy Award Winner Kenny Loggins 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3
... Dynamics Company,Ltd.) (TSX: IDL), the global leader in ... that it has been awarded a contract by,the ... India for,five X-Series 1600 DR systems with X4C ... placed for DR equipment by the government in,India ...
... not be the major cause of hyperactivity in children. Genetics, ... just as important. , A review ... actually affected by what they eat. A combination of food, ... with no single factor to blame. , Foods which ...
... Transplant,Foundation (MTF) will provide military hospitals with special ... for injured servicemen and,women., Military hospitals and ... for cartilage transplantation and meniscus grafts used for,joint ... tissue are in high,demand for U.S. servicemen and ...
... has awarded one of 14 Clinical and Translational Science ... Boston University Medical (BUMC) and Charles River Campuses and ... CTSAs awarded in 2007, and 12 awarded in 2006, ... a national consortium of select centers that will transform ...
... H. Antman, MD, provost of Boston University Medical Campus ... be honored with the Distinguished Service Award for Scientific ... at their annual meeting in Chicago this weekend. Antman, ... cancer, is widely recognized for her development of a ...
... a Useful Tool in Detection, as Sensitive as MRI ... Invasive Cancers and Perhaps More So for DCIS, NEWPORT ... June issue of Radiology, researchers at The George Washington,University Medical ... is highly sensitive in detecting the,presence of cancer. The researchers ...
Cached Medicine News:Health News:IDC awarded India's largest state government contract for digital radiography systems 2Health News:IDC awarded India's largest state government contract for digital radiography systems 3Health News:Children's diet not the main cause of ADHD 2Health News:BUMC, BMC receives Clinical and Translational Science Award from NIH 2Health News:BUMC provost, BUSM dean, to be honored at world's largest meeting of oncology professionals 2Health News:Breast-Specific Gamma Imaging (BSGI) Found to Be Highly Sensitive for Early Stage Breast Cancer 2
Consensus Knee implants are designed to provide both joint and implant stability and allow near normal kinematics. The components are anatomic with porous and nonporous options. Six femoral/tibial an...
Alpina Uni Knee Prosthesis is designed to meet anatomical requirements and particularly the differences between medial and lateral femoral condyles....
The Genesis II total knee system defines the state of knee implants....
... inserts have radiused A/P and M/L ... maximizing conformity of the tibial insert ... femoral component. The resulting rotary arc ... and accommodates the knee's natural screw-home ...
Medicine Products: